Diagnosis and Management of Levator Ani Syndrome in Reproductive-Age Women
Diagnostic Approach
Levator ani syndrome is diagnosed by acute localized tenderness to palpation along the puborectalis muscle during digital rectal examination, which is the key distinguishing feature from other pelvic floor disorders. 1
Essential Clinical Features
- Primary symptom is pain, not difficulty with evacuation, distinguishing it from dyssynergic defecation 1
- Pain episodes last longer than 20 minutes and are typically exacerbated by sitting 2, 3
- Pain may radiate to the vagina, perineum, low back, or buttocks 4, 2
- Rectal examination shows tenderness with normal sphincter tone and coordination 1
- No evidence of paradoxical contraction during simulated defecation 1
Critical Examination Technique
Digital rectal examination must include functional maneuvers: 1
- Assess resting sphincter tone
- Test squeeze augmentation
- Palpate puborectalis for localized tenderness (diagnostic finding)
- Observe perineal descent during simulated evacuation
- Ask patient to "expel my finger" to assess coordination
Vaginal examination should include palpation of levator ani muscles bilaterally, as tenderness elicited during vaginal palpation indicates pelvic floor dysfunction 2, 5
Diagnosis of Exclusion
Levator ani syndrome is a diagnosis of exclusion requiring thorough evaluation to rule out structural causes including: 2
- Anal fissure
- Thrombosed hemorrhoids
- Sexually transmitted diseases
- Proctitis
- Cancer
- Inflammatory bowel disease 2
Imaging (CT, MRI, ultrasound) may be needed to exclude masses, rectoceles, or intussusception before confirming functional diagnosis 1, 2
Patient Stratification for Treatment
Only patients with tenderness on traction of levator muscles during rectal examination ("highly likely" LAS) benefit from treatment 6. Patients without this finding ("possible" LAS) do not respond to any treatment modality 6.
Management Algorithm
First-Line Treatment: Biofeedback
Biofeedback is the most effective treatment for levator ani syndrome and should be the initial therapeutic approach. 6
- 87% of patients with "highly likely" LAS report adequate relief with biofeedback 6
- Pain days per month decrease from 14.7 to 3.3 after biofeedback 6
- Pain intensity decreases from 6.8/10 to 1.8/10 after biofeedback 6
- Treatment protocol: 9 sessions of biofeedback teaching pelvic floor relaxation 6
- Improvements maintained for 12 months 6
- Mechanism: increases ability to relax pelvic floor muscles and reduces urge/pain thresholds 6
Pelvic floor physiotherapy with biofeedback should be initiated as primary treatment 2
Second-Line Treatment: Electrogalvanic Stimulation (EGS)
If biofeedback is unavailable or partially effective: 6
- 45% of patients report adequate relief with EGS 6
- Pain days decrease from 14.7 to 8.9 per month 6
- Pain intensity decreases from 6.8/10 to 4.7/10 6
- Protocol: 9 sessions of EGS 6
- High voltage pulsed galvanic stimulation (HVPGS) at 120 Hz for one hour via rectal probe shows 50% response rate after average of 8 treatments 7
Pharmacological Management
Amitriptyline 20 mg once daily is an appropriate initial pharmacological option 2
Additional pharmacological options include: 2
- Non-steroidal anti-inflammatory medications
- Diazepam (including rectal formulation) 3
- Gabapentin
- Botulinum toxin
Trigger Point Injections
For patients with specific palpable levator ani trigger points, trigger point injections achieve 72% comprehensive success rate 5
Protocol: 5
- Identify trigger points by intravaginal palpation of levator ani bilaterally
- Inject 5 cc per trigger point using mixture of 10 cc 0.25% bupivacaine, 10 cc 2% lidocaine, and 1 cc (40 mg) triamcinolone
- Use 5.5" Iowa trumpet pudendal needle guide
- Office-based procedure without sedation
- Success defined as ≥50% pain reduction on VAS and ≥60% patient global satisfaction
- 33% of patients become completely pain free 5
- Mean follow-up 3 months 5
- Teach pelvic floor muscle exercises for use after injection 5
Least Effective Treatment: Massage
Massage of levator muscles is the least effective treatment and should not be recommended as primary therapy 6
- Only 22% report adequate relief 6
- Pain days decrease minimally from 14.7 to 13.3 per month 6
- Pain intensity remains essentially unchanged (6.8/10 to 6.0/10) 6
Adjunctive Measures
Critical Clinical Pitfalls
Do not prescribe standard laxatives for levator ani syndrome - the treatment is fundamentally different from constipation management, as patients have pain rather than evacuatory difficulty 1
Do not assume normal digital examination excludes pelvic floor dysfunction - imaging or specialized testing may still be warranted 1
Patients who are unresponsive to HVPGS typically have primary diagnosis of irritable colon or are post-surgical 7 - consider these factors when selecting treatment modality
Atypical presentations exist: some patients present with perianal hyperhidrosis, tenesmus, urgency, or sensation of incomplete evacuation rather than classic pain 3 - maintain high index of suspicion and perform thorough digital examination
Relationship to Childbirth in Reproductive-Age Women
Levator ani muscle injury from vaginal birth increases risk of pelvic floor dysfunction 4
- Forceps delivery associated with greater maternal tissue damage despite being protective for fetus 4
- Women with levator ani avulsion have greater risk of symptomatic prolapse 4
- High rate of prior pelvic surgery (especially hysterectomy) in women with levator ani pain suggests trauma or local factors may contribute 4